Göttingen, Germany | April 9, 2024 Collaboration to advance TheWell Bioscience animal-free hydrogel solutions for 3D cell models Solutions address shift from animal-based to more human-relevant organoid models, resulting in more accurate predictions in drug discovery Synergies with Sartorius bioanalytical lab instruments for cell imaging The life science group Sartorius and U.S.-based startup TheWell Bioscience […]
NORTH BRUNSWICK, N.J., Dec. 18, 2023 /PRNewswire/ — TheWell Bioscience, a pioneer of 3D biomimicking platforms for precision medicine, cell therapy, and biomanufacturing, announces the launch of VitroGel®-Based Cell Invasion Assay Kits. Using the xeno-free VitroGel® hydrogels, these new kits revolutionize how researchers study cell migration and invasion, offering unprecedented accuracy, efficiency, and reliability for cell migration assays. […]
TheWell Bioscience has launched a newly engineered version of its cell recovery solution for researchers to speed the organoid/cell harvesting from both animal-based extracellular matrix (ECM) and synthetic hydrogels. NEW BRUNSWICK, N.J., Feb. 21, 2023 /PRNewswire/ — TheWell Bioscience, a pioneer of 3D cell culture platforms for precision medicine, cell therapy, and biomanufacturing, releases a newly engineered […]
North Brunswick, NJ., January 16, 2020 – TheWell Bioscience Inc, a biotech company focusing on 3D cell culture, launches VitroINK™, a new series of xeno-free tunable bioink system that requires no UV, no temperature/pH curing or chemical crosslinking. The new bioinks are ready-to-use at room temperature, have excellent visibility after printing, and can incorporate multiple […]
